Hamill John P.

Track

Insider profile

Performance

Overall performance
2.6
Performance over holding periods
2.6
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 36% 68% 82%
Transactions
6 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Hamill John P.'s trades of Aprea Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-02 2026-01-30
B Purchase
34,073 -47.8%
430.12
US$4,597,741 		34,073 -47.8% 430.12 US$4,597,741
2025-12-11 2025-12-10
B Purchase
88,187 -7.7%
364.31
US$383,894 		88,187 -7.7% 364.31 US$383,894
2024-10-16 2024-10-11
B Purchase
84,554 +2.7%
225.22
US$2,490,485 		84,554 +2.7% 225.22 US$2,490,485
2024-10-15 2024-10-10
B Purchase
450 +2.4%
2.61
US$1,174 		450 +2.4% 2.61 US$1,174
2024-03-14 2024-03-13
B Purchase
1,010 +7.0%
7.29
US$7,363 		1,010 +7.0% 7.29 US$7,363
2022-07-26 2022-07-26
B Purchase
3,000 +4.3%
0.37
US$1,100 		3,000 +4.3% 0.37 US$1,100
2021-03-25 2021-03-25
B Purchase
1,500 +150.0%
3.25
US$4,875 		1,500 +150.0% 3.25 US$4,875
2020-10-09 2020-10-07
B Purchase
1,000 +inf%
5.27
US$5,270 		1,000 +inf% 5.27 US$5,270
2019-06-04 2019-05-31
US Trevena Inc (TRVN)
B Purchase
7,500 +9.3%
1.16
US$8,700 		7,500 +9.3% 1.16 US$8,700